Archangels
investing in innovation
?>


Archangels Appoints Investment Executive – Shaolei McKie

  Shaolei McKie has joined Archangels as our Investment Executive. Shaolei will support the Executive Team in undertaking due diligence, business performance analysis, legal and investor liaison both for Archangels’ existing …

Largest Ever Round Lead by Archangels: £3.5m Investment in ZoneFox

Leading cyber-security software specialist ZoneFox, has today closed a £3.6 million Series A funding round. The round is led by Scottish business angel investment syndicate, Archangels, with co-investment from The …

Archangels “Backs” PhysioWizard

  Archangels, with support from Scotland’s leading medtech and digital health incubator, MediCity Scotland (part of the BioCity Group) has invested in Scottish early stage company, PhysioMedics, whose expert system, …

John Waddell – Winner of Dealmaker of the Year!

The Scottish Business Insider Deals & Dealmakers Awards were held in Glasgow on the 7th of September 2016. The executive team from Archangels attended the event hosted by Fred Macaulay, …

The bionic span: how a Scottish prosthetic hand developer attained global reach

“Five of our board members invested £5,000 each to help David build his prototype. It had what we look for in a startup – a clever, difficult-to-copy technology that had …

NCTech and Top Gear USA Film the Rubicon Trail in 360′

NCTech and Top Gear USA have captured the Rubicon Trail in 360′, in one of Google’s largest independent projects. The iSTAR® camera was put to the test, filming in extreme conditions …

Bloxx acquired by Akamai Technologies, Inc.

Livingston-based Bloxx, the provider of real-time Internet and email filtering solutions, has been sold by its shareholders – including Archangel Investors and Scottish Investment Bank – to US-based Akamai Technologies, …

Archangels Impact Evaluation Report

We are delighted that Deputy First Minister John Swinney, MSP will be joining us at the Strathclyde University Technology and Innovation Centre in Glasgow to launch the findings of a …

Dundee-based CXR Biosciences Joins Concept Life Sciences Group

CXR Biosciences Limited, (“CXR”) the Dundee-based investigative and exploratory toxicology business, has been sold by its shareholders – including Archangel Investors and Scottish Investment Bank – to UK-based Concept Life …

MGB Biopharma commences Phase I clinical trial with oral formulation of MGB-BP-3 for the treatment of multi-resistant Clostridium Difficile infections

MGB Biopharma is at the forefront of efforts to tackle the global rise in antibiotic resistant infections Glasgow, Scotland, 21st July 2015 – MGB Biopharma, a biopharmaceutical company developing a …